Adapting to Change, Accelerating with AI, Excelling with Resilience
November 18 - 19, 2025
| Free PEX Network Webinar Series
Jeff Alker
Solutions Consultant BusinessOptix
Jeff Alker is a seasoned business process and enterprise architecture leader with over two decades of experience driving process excellence across industries including pharmaceuticals, financial services, retail, government, and technology. His career journey spans roles as IT Director, Business Consultant, Enterprise Architect, and Senior Business Architect, where he has consistently delivered transformative solutions that improve efficiency, reduce costs, and enhance organizational agility. Jeffrey has worked with global leaders such as Abbvie, Nike, SiriusXM, Aflac, Astellas Pharmaceuticals, Pfizer, and the U.S. Army Corps of Engineers, leveraging expertise in business process modeling, Pega applications, and enterprise architecture frameworks such as TOGAF and DoDAF. Recognized for his ability to bridge business needs with technical implementation, he has led large-scale transformation initiatives, facilitated enterprise workshops, and mentored cross-functional teams. A certified Six Sigma Black Belt and Pega Methodology Black Belt, Jeffrey combines strategic insight with hands-on leadership to help organizations unlock measurable business value through process analysis and continuous improvement.
Day One
10:30 AM Setting the Foundation for AI in the Future of Process Excellence
How AbbVie and BusinessOptix are building visibility, agility, and readiness for AI-driven transformation.
AI is reshaping the way organizations approach operational excellence, but real success depends on what comes first: building the foundation. In this fireside chat, Joy Shelledy, Director, Strategic Change Enablement, AbbVie; Amanda Swearengen, Director II, Strategic Change Enablement, AbbVie and Jeff Alker, Solutions Consultant, BusinessOptix, will explore how life sciences leaders can map and model processes to create end-to-end visibility, test scenarios before committing to automation, and establish ROI long before bots or AI are deployed.
The discussion will highlight AbbVie’s journey, in documenting their end-to-end clinical trial processes leveraging the BusinessOptix platform and how this sets them up for the next wave of innovation. Beyond technology, the speakers will address the human side of transformation, including organizational agility, change management and sustaining impact across the enterprise.
- Why foundational process mapping and simulation are essential before committing to a process improvement
- How to apply a “try before you buy” approach to validate ROI and reduce transformation risk
- The role of organizational agility and change management in sustaining transformation success
- How leaders can set the stage today for long-term impact from AI and digital transformation initiatives
In Partnership With:
©2025 IQPC. All rights reserved.
